个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共9条记录  
  • BRIVARACETAM SV2A Ligand Antiepileptic Drug
    [作者:Bestha, DP; Yang, B; Madaan, V,期刊:Drugs of the Future, 页码:165-172 , 文章类型: Article,,卷期:2010年35-3]
  • Brivaracetam is a racetam derivative with anticonvulsant properties. It binds to synoptic vesicle glycoprotein 2A (SV2A) to produce its clinical effect. Brivaracetam is believed to have brood antiseizure activity, a rela...
  • PEPTIDE-BASED ANTIFUNGAL THERAPIES AGAINST EMERGING INFECTIONS
    [作者:Matejuk, A; Leng, Q; Begum, MD; Woodle, MC; Scaria, P; Chou, ST; Mixson, AJ,期刊:Drugs of the Future, 页码:197-217 , 文章类型: Review,,卷期:2010年35-3]
  • Acquired drug resistance to mycotic infections is rapidly emerging as a major medical problem. Opportunistic fungal infections create therapeutic challenges, particularly in high-risk immunocompromised patients with AIDS...
  • RAXIBACUMAB Treatment of Anthrax Infection
    [作者:Adusumilli, S,期刊:Drugs of the Future, 页码:179-182 , 文章类型: Article,,卷期:2010年35-3]
  • Raxibacumab, a human monoclonal IgG(1 lambda) antibody, is effective in the treatment of Bacillus anthracis infection or anthrax toxin exposure in animal studies due to its ability to inhibit the binding of B. anthracis ...